Constance CareWAR:CCR 33 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:CCR with a GF Score™ of 33/100 and a GF Value™ of zł0.15 (Significantly Overvalued). Among 668 Healthcare Providers & Services companies, Constance Care ranks worse than 149700.45% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Constance Care's Net Income for the
three
months ended in Mar. 2026 was zł-0.01 Mil. Constance Care's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, Constance Care's net margin for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Constance Care's Net Margin % or its related term are showing as below:
WAR:CCR's Net Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.885 * Ranked among companies with meaningful Net Margin % only.
Constance Care (WAR:CCR) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Constance Care Net Margin % Related Terms
Constance Care Net Margin % Historical Data
* Premium members only.
The historical data trend for Constance Care's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Constance Care's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Constance Care Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Constance Care's Net Margin % distribution charts can be found below:
* The bar in red indicates where Constance Care's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Constance Care (WAR:CCR) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Constance Care and its competitors. According to the industry distribution chart, Constance Care ranks #999999 out of 668 companies in the Healthcare Providers & Services industry.
Is Constance Care's Net Margin % too high?
Constance Care's current Net Margin % is 0.00%. Based on the distribution chart, Constance Care ranks #999999 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Constance Care has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Constance Care's Net Margin % compare to HCA and UHS?
According to the Healthcare Providers & Services industry distribution chart, Constance Care ranks #999999 out of 668 companies for Net Margin %. This places Constance Care in the lower half of its industry. The industry median Net Margin % is 2.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Constance Care and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Constance Care's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Constance Care stock overvalued right now?
Based on GuruFocus' analysis, Constance Care (WAR:CCR) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.15, compared to a current price of zł6.00 — trading 3900% above its estimated fair value. The current Net Margin % is 0.00%. Constance Care's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Constance Care (WAR:CCR), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Constance Care (WAR:CCR) Overvalued in 2026?
Based on GuruFocus' analysis, Constance Care stock appears to be overvalued.
The current stock price of zł6.00 is trading 3900% above its estimated GF Value™ of zł0.15.
GuruFocus considers Constance Care to be Significantly Overvalued.
Key valuation signals for WAR:CCR:
Net Margin %: 0.00%
GF Value™: zł0.15 vs. price of zł6.00 (3900% above fair value)
No single metric tells the full story. See the WAR:CCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.
33GF Score
Get the complete analysis for WAR:CCR
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CCR has been successfully added to your 
